𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Transcatheter arterial embolization for advanced hepatocellular carcinoma: The controversy continues

✍ Scribed by Shuichi Okada


Publisher
John Wiley and Sons
Year
1998
Tongue
English
Weight
30 KB
Volume
27
Category
Article
ISSN
0270-9139

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


A pilot study of transcatheter arterial
✍ Man-Fung Yuen; Clara Gaik-Cheng Ooi; Chee-Kin Hui; Wai-Man Wong; Benjamin Chun-Y πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 129 KB

## Abstract ## BACKGROUND Systemic, high–dose interferon‐α treatment given three times per week subcutaneously induces tumor regression in approximately 30% of patients with inoperable hepatocellular carcinoma (HCC). The objective of the current study was to determine the efficacy and safety of tr

A comparative study of hepatic resection
✍ Takashi Kanematsu; Takashi Matsumata; Ken Shirabe; Keizo Sugimachi; Shigeru Saka πŸ“‚ Article πŸ“… 1993 πŸ› John Wiley and Sons 🌐 English βš– 537 KB

Background. Because transcatheter arterial embolization (TAE) has been shown to be effective in patients with unresectable hepatocellular carcinoma (HCC), the question arises whether TAE has an equivalent or superior effect on resectable HCC compared with surgery. To clarify this point, the authors

Interleukin-6 in transcatheter arterial
✍ Yukihiko Matsuda; Sumio Kawata; Toshihiko Nagase; Yuichi Maeda; Eiji Yamasaki; S πŸ“‚ Article πŸ“… 1994 πŸ› John Wiley and Sons 🌐 English βš– 446 KB πŸ‘ 2 views

Background. Modulation of serum levels of circulating cytokines and inflammatory responses with a serine protease inhibitor was studied in 34 patients with hepatocellular carcinoma (HCC) after transcatheter arterial embolization (TAE). Methods. The 34 patients were randomly divided into two groups: